Literature DB >> 8363391

Ciprofloxacin susceptibility testing by MIC and disk elution of drug-resistant Mycobacterium tuberculosis and Mycobacterium avium complex.

V J LaBombardi1, L Cataldo-Caputzal.   

Abstract

The ability to provide susceptibility data for certain species of mycobacteria can be clinically useful. In this study, the disk elution method for susceptibility testing was adapted for testing ciprofloxacin against mycobacterial isolates. Of the 75 Mycobacterium tuberculosis isolates tested, including 23 multiply drug-resistant isolates, 96% were susceptible to ciprofloxacin at a breakpoint concentration of 2 micrograms/ml.

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8363391      PMCID： PMC188013          DOI： 10.1128/AAC.37.7.1556

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  11 in total

1.  The in-vitro bactericidal activities of combinations of antimicrobial agents against clinical isolates of Mycobacterium avium-intracellulare.

Authors:  R J Kent; M Bakhtiar; D C Shanson
Journal:  J Antimicrob Chemother       Date:  1992-11       Impact factor: 5.790

2.  Ciprofloxacin treatment of multiply drug-resistant extrapulmonary tuberculosis in a child.

Authors:  G Hussey; M Kibel; N Parker
Journal:  Pediatr Infect Dis J       Date:  1992-05       Impact factor: 2.129

Review 3.  Mycobacteria and the new quinolones.

Authors:  D C Leysen; A Haemers; S R Pattyn
Journal:  Antimicrob Agents Chemother       Date:  1989-01       Impact factor: 5.191

4.  Evidence that antituberculosis drugs are really effective in the treatment of pulmonary infection caused by Mycobacterium avium complex.

Authors:  M Tsukamura
Journal:  Am Rev Respir Dis       Date:  1988-01

5.  Treatment of disseminated Mycobacterium avium complex infection in AIDS with amikacin, ethambutol, rifampin, and ciprofloxacin. California Collaborative Treatment Group.

Authors:  J Chiu; J Nussbaum; S Bozzette; J G Tilles; L S Young; J Leedom; P N Heseltine; J A McCutchan
Journal:  Ann Intern Med       Date:  1990-09-01       Impact factor: 25.391

6.  Successful treatment of acquired immunodeficiency syndrome-related Mycobacterium avium complex disease with a multiple drug regimen including amikacin.

Authors:  C A Benson; H A Kessler; J C Pottage; G M Trenholme
Journal:  Arch Intern Med       Date:  1991-03

7.  In vitro activity of the new quinolone lomefloxacin against Mycobacterium tuberculosis.

Authors:  C Piersimoni; V Morbiducci; S Bornigia; G De Sio; G Scalise
Journal:  Am Rev Respir Dis       Date:  1992-12

8.  Response to therapy of pulmonary Mycobacterium avium-intracellulare infection correlates with results of in vitro susceptibility testing.

Authors:  C R Horsburgh; U G Mason; L B Heifets; K Southwick; J Labrecque; M D Iseman
Journal:  Am Rev Respir Dis       Date:  1987-02

9.  MYCOBACTERIA: LABORATORY METHODS FOR TESTING DRUG SENSITIVITY AND RESISTANCE.

Authors:  G CANETTI; S FROMAN; J GROSSET; P HAUDUROY; M LANGEROVA; H T MAHLER; G MEISSNER; D A MITCHISON; L SULA
Journal:  Bull World Health Organ       Date:  1963       Impact factor: 9.408

10.  Comparative in vitro activities of ciprofloxacin and other 4-quinolones against Mycobacterium tuberculosis and Mycobacterium intracellulare.

Authors:  C H Fenlon; M H Cynamon
Journal:  Antimicrob Agents Chemother       Date:  1986-03       Impact factor: 5.191
View more
  3 in total

1.  Multicenter laboratory validation of susceptibility testing of Mycobacterium tuberculosis against classical second-line and newer antimicrobial drugs by using the radiometric BACTEC 460 technique and the proportion method with solid media.

Authors:  G E Pfyffer; D A Bonato; A Ebrahimzadeh; W Gross; J Hotaling; J Kornblum; A Laszlo; G Roberts; M Salfinger; F Wittwer; S Siddiqi
Journal:  J Clin Microbiol       Date:  1999-10       Impact factor: 5.948

2.  Pyrosequencing for rapid detection of Mycobacterium tuberculosis resistance to rifampin, isoniazid, and fluoroquinolones.

Authors:  Lulette Tricia C Bravo; Marion J Tuohy; Concepcion Ang; Raul V Destura; Myrna Mendoza; Gary W Procop; Steven M Gordon; Geraldine S Hall; Nabin K Shrestha
Journal:  J Clin Microbiol       Date:  2009-10-21       Impact factor: 5.948

3.  In vitro activity of ciprofloxacin, ofloxacin and levofloxacin against Mycobacterium tuberculosis.

Authors:  Sinem Akcali; Suheyla Surucuoglu; Candan Cicek; Beril Ozbakkaloglu
Journal:  Ann Saudi Med       Date:  2005 Sep-Oct       Impact factor: 1.526
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.